BioLife Solutions, Inc. Cost of Revenue
BioLife Solutions, Inc. (BLFS) reported Cost of Revenue of $10.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-06
- BioLife Solutions, Inc. cost of revenue for the quarter ending 2026-06-30 was $10.18M, a 24.09% increase year-over-year.
- BioLife Solutions, Inc. cost of revenue for the quarter ending 2026-03-31 was $10.00M, a 37.91% increase year-over-year.
- BioLife Solutions, Inc. cost of revenue for the quarter ending 2025-06-30 was $8.20M.
- BioLife Solutions, Inc. cost of revenue for the quarter ending 2025-03-31 was $7.25M.
- BioLife Solutions, Inc. cost of revenue for fiscal 2025 was $34.10M, a 38.88% increase from fiscal 2024.
- BioLife Solutions, Inc. cost of revenue for fiscal 2024 was $24.55M, a 8.04% decline from fiscal 2023.
- BioLife Solutions, Inc. cost of revenue for fiscal 2023 was $26.70M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|---|
| 2026-06-30 | $10.18M 10-Q · filed 2026-08-06 | $20.18M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $10.00M 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $34.10M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $8.20M 10-Q · filed 2026-08-06 | $15.46M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $7.25M 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $24.55M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $26.70M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |